Primary Site >> Colorectal Cancer
Gene >> TAB2
| 1. | |||||||||||
| Journal: | Bioconjug Chem. 2006 Mar-Apr;17(2):410-8. | ||||||||||
| Title: | Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT). | ||||||||||
| Author: | Alderson, Ralph F|Toki, Brian E|Roberge, Martin|Geng, Wei|Basler, Joshua|Chin, Regina|Liu, Amy|Ueda, Roanna|Hodges, Douglas|Escandon, Enrique|Chen, Tianling|Kanavarioti, Tessi|Babe, Lilia|Senter, Peter D|Fox, Judith A|Schellenberger, Volker | ||||||||||
| PMID: | 16536473 | ||||||||||
| 2. | |||||||||||
| Journal: | Curr Cancer Drug Targets. 2011 Oct;11(8):976-86. | ||||||||||
| Title: | RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors. | ||||||||||
| Author: | Martin, S E|Wu, Z-H|Gehlhaus, K|Jones, T L|Zhang, Y-W|Guha, R|Miyamoto, S|Pommier, Y|Caplen, N J | ||||||||||
| PMID: | 21834757 | ||||||||||
| 3. | |||||||||||
| Journal: | Biomed Res Int. 2013;2013:159786. | ||||||||||
| Title: | Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells. | ||||||||||
| Author: | Kan, Jung-Yu|Hsu, Ya-Ling|Chen, Yen-Hsu|Chen, Tun-Chieh|Wang, Jaw-Yuan|Kuo, Po-Lin | ||||||||||
| PMID: | 24386633 | ||||||||||